DGAP-Adhoc: Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share.


 

DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Change in Forecast/Preliminary Results
Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share.

22-Jul-2019 / 19:19 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Insider information pursuant to Article 17 MAR

Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share

Berlin, 22 July 2019. According to initial analyses, revenues and earnings of the Berlin based isotope specialists Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) as of June 30 were significantly higher than expected. While sales of EUR 81.0 million were generated in 2018 with continuing operations, this value is expected to have increased by 10% to EUR 89.0 million as of the half-year reporting date in 2019. In the same period, the earnings from continuing operations increased by 56% from EUR 1.65 to EUR 2.59 per share according to preliminary figures.

Since the 2019 half-year result contains only a few extraordinary items and most main product groups continue to be in good demand, the Executive Board expects that the consolidated result from continuing operations for fiscal year 2019 to exceed the forecast published at the beginning of the year. The previous target of EUR 3.50 is therefore increased to EUR 4.00 per share.

The complete figures for the first half year 2019 will be published on 13 August 2019.

Your contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.de


22-Jul-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 844899

 
End of Announcement DGAP News Service

844899  22-Jul-2019 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=844899&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2012 2013 2014 2015 2016 2017 2018 2019e
Umsatzerlöse1 120,00 117,14 127,26 139,75 137,94 138,63 168,71 180,00
EBITDA1,2 27,48 22,07 20,10 26,98 24,97 26,62 32,14 32,30
EBITDA-Marge3 22,90 18,84 15,79 19,31 18,10 19,20 19,05 17,94
EBIT1,4 19,73 12,82 12,96 18,22 16,23 17,97 23,39 23,50
EBIT-Marge5 16,44 10,94 10,18 13,04 11,77 12,96 13,86 13,06
Jahresüberschuss1 10,29 9,09 6,50 10,37 9,79 15,12 16,89 19,00
Netto-Marge6 8,58 7,76 5,11 7,42 7,10 10,91 10,01 10,56
Cashflow1,7 16,57 14,65 10,65 16,23 19,83 26,83 21,21 22,50
Ergebnis je Aktie8 1,95 1,72 1,28 2.03 1,81 2,78 3,12 4,10
Dividende8 0,60 0,60 0,60 0,60 0,66 0,80 1,20 1,40
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2018 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Eckert & Ziegler
WKN Kurs in € Einschätzung Börsenwert in Mio. €
565970 188,000 Halten 995,08
KGV 2020e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
44,76 17,26 2,594 94,00
KBV KCV KUV EV/EBITDA
7,66 46,92 5,90 29,695
Dividende '19 in € Dividende '20e in € Div.-Rendite '19e
in %
Hauptversammlung
1,40 1,40 0,74 17.06.2020
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
12.05.2020 13.08.2020 12.11.2019 31.03.2020
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
12,41% 51,19% 204,70% 181,86%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Eckert & Ziegler Strahlen- und Medizintechnik AG  ISIN: DE0005659700 können Sie bei DGAP abrufen

Medtech , 565970 , EUZ , XETR:EUZ